Galectin Therapeutics Inc.
GALT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$47 | -$41 | -$39 | -$31 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $3 | $2 |
| Change in WC | $2 | $5 | $5 | $4 |
| Other Non-Cash | $1 | $1 | -$0 | $0 |
| Operating Cash Flow | -$42 | -$33 | -$31 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $30 | $30 | $10 | $30 |
| Stock Issued | $1 | $0 | $0 | $7 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$0 | $0 | $0 | -$0 |
| Other Fin. Act. | $0 | $10 | $0 | $0 |
| Financing Cash Flow | $31 | $40 | $10 | $37 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11 | $7 | -$21 | $13 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26 | $19 | $40 | $27 |
| End Cash | $15 | $26 | $19 | $40 |
| Free Cash Flow | -$42 | -$33 | -$31 | -$24 |